-

CG Life Forms Strategic Communications Group to Integrate Corporate, Scientific and Medical Communications and Social Media Services

Biopharma communications leader Karen Sharma joins CG Life as Senior Vice President, enhancing expertise in helping precision medicine companies connect with business, clinical, research, and patient audiences

BOSTON & CHICAGO & SAN DIEGO--(BUSINESS WIRE)--CG Life, the science-first, tech-enabled marketing and communications partner to precision medicine and life science companies, has formalized the agency’s public relations and social media teams and capabilities into a Strategic Communications Group to support its clients in more dynamic and integrated ways. The move comes as a culmination of the successful integration of the recently acquired public relations agency Berry & Company.

“Our Strategic Communications Group is uniquely positioned to help companies in the rare disease and precision medicine spaces use their stories and science to make an impact,” said CG Life CEO David Ormesher. “Because we focus on a deep understanding of both the science and those touched by science, our teams can create highly personalized experiences powered by technology to create meaningful engagement, build strong brands and brand value, and ultimately help to drive positive patient outcomes.”

Longstanding CG Life managing partner Erik Clausen leads the group, which features centers of excellence in the areas of scientific, medical, and corporate communications, as well as social media. In addition, the group offers deep expertise in patient advocacy initiatives and includes a multi-disciplinary business and crisis communications advisory team providing senior counsel to C-suites.

“Emerging pharma faces unprecedented complexity on the path to commercialization and must overcome many challenges to lift the patients they serve,” said Clausen, Strategic Communications Group managing director. “Through smart, coordinated planning, it’s possible for these companies to communicate strategically and simultaneously to corporate, clinical, and research stakeholders throughout pre-clinical and commercial stages.”

With this move, CG Life also recently welcomed Boston-based Karen Sharma as Senior Vice President of Public Relations. She brings to the role more than 20 years of public relations, corporate, and crisis communications experience in life science and healthcare. Previously, Sharma served as Managing Partner of MacDougall Advisors, a premier public relations and business advisory firm serving biopharma.

“The decision to join the CG Life team was a very easy one. I’ve long held a deep respect for this agency team, and I know that the respect has been mutual,” said Sharma. “Becoming a part of such a talented and enthusiastic team that is passionate about both the science and the art of storytelling is a joy. Our group will benefit clients by shaping and delivering their insights, innovations, and breakthroughs to the audiences that need to learn about them most.”

About CG Life

For more than two decades, CG Life has provided integrated marketing solutions to companies leading the way in therapeutics, medical devices, diagnostics, and research tools and services. Committed to the profound impact of science on everyday lives, CG Life blends scientific understanding, strategic imagination, and digital innovation to guide clients through the biggest leaps they make. Visit cglife.com to learn more.

Contacts

Liz Robinson
CG Life
lrobinson@cglife.com

CG Life

Details
Headquarters: Chicago, Illinois
CEO: David Ormesher
Employees: 150
Organization: PRI

Release Versions

Contacts

Liz Robinson
CG Life
lrobinson@cglife.com

More News From CG Life

New 24/364 Film “Dylan Findling” Captures One Family’s Refusal to Let a Rare Disease Define Their Son’s Life

CHICAGO & NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Dylan Findling, a powerful new short documentary from 24/364, debuts today as the second film in the In the Light series, offering an intimate look at the life of Dylan Findling and his family determined to keep living, hoping and fighting in the face of a devastating rare disease diagnosis.At nine years old, Dylan was an active kid who loved basketball, drawing, and spending time outside. Then his family learned that he had adrenoleukodystrophy (...

CG Life Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

CHICAGO & SAN DIEGO & NEW YORK--(BUSINESS WIRE)--CG Life, a specialized pharma agency built for the unique challenges of bringing therapies for rare, specialty, and hard-to-treat diseases to market, has been named to the 2026 Inc. 5000, an annual ranking of the fastest-growing private companies in America. The national honor recognizes CG Life for its continued business growth and significant expansion of its role as a commercialization partner for biopharma companies. Last month, CG Life combi...

CG Life Combines With AI-Native Agency The Considered+AI to Create a New Model of Commercialization Partner

CHICAGO & NEW YORK & SAN DIEGO--(BUSINESS WIRE)--CG Life, a specialized pharma agency built for the unique challenges of bringing therapies for rare, specialty, and hard-to-treat diseases to market, has combined with The Considered+AI, an AI-native agency built from inception for the era of generative AI. The union blends CG Life’s rare disease and precision medicine expertise with The Considered’s proven approach to amplifying world-class talent through AI to commercialize therapies with great...
Back to Newsroom